A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer (MONARCH 2)

Clinical Trial ID NCT02107703

PubWeight™ 12.03^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02107703

Top papers